These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7743400)

  • 1. Brain metabolic function in older men with chronic essential hypertension.
    Salerno JA; Grady C; Mentis M; Gonzalez-Aviles A; Wagner E; Schapiro MB; Rapoport SI
    J Gerontol A Biol Sci Med Sci; 1995 May; 50(3):M147-54. PubMed ID: 7743400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism.
    Szymanski S; Gur RC; Gallacher F; Mozley LH; Gur RE
    Neuropsychopharmacology; 1996 Dec; 15(6):567-75. PubMed ID: 8946431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
    Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilson's disease studied with FDG and positron emission tomography.
    Hawkins RA; Mazziotta JC; Phelps ME
    Neurology; 1987 Nov; 37(11):1707-11. PubMed ID: 3499583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
    Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
    Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution PET studies in Alzheimer's disease.
    Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
    Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual metabolic anatomy of repeating words demonstrated by MRI-guided positron emission tomography.
    Herholz K; Pietrzyk U; Karbe H; Würker M; Wienhard K; Heiss WD
    Neurosci Lett; 1994 Nov; 182(1):47-50. PubMed ID: 7891885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study.
    Miura SA; Schapiro MB; Grady CL; Kumar A; Salerno JA; Kozachuk WE; Wagner E; Rapoport SI; Horwitz B
    J Neurosci Res; 1990 Dec; 27(4):500-4. PubMed ID: 2079712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia.
    Rottenberg DA; Sidtis JJ; Strother SC; Schaper KA; Anderson JR; Nelson MJ; Price RW
    J Nucl Med; 1996 Jul; 37(7):1133-41. PubMed ID: 8965184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 14. The Marinesco-Sjögren syndrome examined by computed tomography, magnetic resonance, and 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography.
    Bromberg MB; Junck L; Gebarski SS; McLean MJ; Gilman S
    Arch Neurol; 1990 Nov; 47(11):1239-42. PubMed ID: 2241622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism.
    Cinotti L; Croisile B; Laurent B; Le Bars D; Malbezin M; Mauguière F
    Eur Neurol; 1995; 35 Suppl 1():17-22. PubMed ID: 8529724
    [No Abstract]   [Full Text] [Related]  

  • 16. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
    Choi Y; Hawkins RA; Huang SC; Gambhir SS; Brunken RC; Phelps ME; Schelbert HR
    J Nucl Med; 1991 Apr; 32(4):733-8. PubMed ID: 2013815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age.
    Loessner A; Alavi A; Lewandrowski KU; Mozley D; Souder E; Gur RE
    J Nucl Med; 1995 Jul; 36(7):1141-9. PubMed ID: 7790936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
    Kling AS; Metter EJ; Riege WH; Kuhl DE
    Am J Psychiatry; 1986 Feb; 143(2):175-80. PubMed ID: 3946650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety levels in dreams: relation to localized cerebral glucose metabolic rate.
    Gottschalk LA; Buchsbaum MS; Gillin JC; Wu JC; Reynolds CA; Herrera DB
    Brain Res; 1991 Jan; 538(1):107-10. PubMed ID: 2018922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.